Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Premenopausal Women With Defined Deleterious Mutations Of Various Genes
• Age: Between 30 years - 50 years
• Gender: Female

• Other Inclusion Criteria:
  

  1.  Patients must be willing to undergo two surgical procedures

  2.  Patients should have at least 1 fallopian tube and 1 ovary

  3.  Patient who are premenopausal must have documented deleted mutations in one of the following ovarian cancer genes:  BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, BARD1, MSH2, MSH6, MLH1, PMS2, or EPCAM

  
  

You may not be eligible for this study if the following are true:

• 1.  Patients with a personal history of ovarian, fallopian tube, or primary peritoneal cancer

  2.  Patients on current treatment with Tamoxifen or Aromatase inhibitors

  3.  Patients who are pregnant or post-partum (within 3 months of delivery)

  4.  Patients with elevated levels of CA125 (> 50) or transvaginal ultrasound suggesting cancer, unless findings are consistent with endometriosis